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Abstract
Background Over 2 million people in England were estimated to be eligible for bariatric surgery in 2006. In 2014, clinical
guidelines were updated, widening potential eligibility, meanwhile, obesity prevalence rose. However, numbers receiving sur-
gery decreased, and concerns exist of inequalities in access between population groups. This study is aimed at estimating the
number of adults eligible for surgery in England and to compare demographics with those that receive surgery.
Methods BMI and comorbidity status were used to determine eligibility for bariatric surgery within participants of the 2014
Health Survey for England dataset (6938 adults), based on the National Institute of Health and Care Excellence guidelines.
Results were scaled up using national population estimates. The demographics of eligible participants were compared against
2014/2015 hospital episode statistics for sex and age group using a chi-squared analysis.
Results Of the total population of England, 7.78% (95%CI 7.1–8.6%), or 3,623,505 people, could have been eligible for bariatric
surgery in 2014; nearly a million more than if previous guidelines applied. Eligibility peaked at ages 45–54, with most in the 35–
64 age group (58.9%). 58.4% of those eligible were women. Patients receiving surgery were far more likely to be female than
male (76.1%) and the distribution skewed towards younger ages when compared with those eligible.
Conclusion Bariatric surgery may benefit many people in England; significant investment is required so that service provision is
adequate for demand. Differences between demographics of those eligible and receiving surgery may be explainable; however,
the potential health inequality should be investigated.
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Introduction
Obesity is a worldwide health problem, being linked to re-
duced life expectancy and multiple comorbidities [1, 2]. An
analysis of the 2016 Health Survey for England (HSE) data
found that 26% of men and 27% of women were obese in the
UK (defined as BMI of 30 kg/m2 or above) [3]. Recent esti-
mates for the cost to the NHS for overweight and obese patients
estimate it to be around £6.05 billion per year [4]. Effective
prevention and treatment is needed to reduce these numbers,
to help improve the life expectancy and quality of life of pa-
tients, and to reduce the economic burden on the NHS.
In 2014, the UK National Institute for Clinical Excellence
(NICE) guidelines for BObesity: identification, assessment
and management^ were updated from the 2006 guidelines.
The current NICE guidelines recommend bariatric surgery as
a treatment for those with a body mass index (BMI) above
40 kg/m2, or between 35 and 39.5 kg/m2 if other significant
diseases are present that could be improved with weight loss.
The recommendation for surgery in these groups is dependent
on other factors, such as trying all appropriate non-surgical
measures (usually behavioural interventions and potentially
pharmacological interventions). Patients with a BMI above
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50 kg/m2 are eligible for bariatric surgery regardless of wheth-
er they have tried lifestyle or drug interventions. These sec-
tions of the guidelines are the same as in the previous guide-
lines. The new guidance introduced allows bariatric surgery as
a first-line treatment for those with recent-onset type two dia-
betes and a BMI of 30–34.9 kg/m2, with an expedited assess-
ment recommended if they have a BMI above 35 kg/m2.
Recent-onset type two diabetes is defined as those whose di-
agnosis has beenmade within a 10-year time frame, within the
NICE guidance. Patients with an Asian ethnic background
should be considered for bariatric surgery Bat a lower BMI
than other populations^ [5].
A previous study showed that more than 2 million people
could be eligible for bariatric surgery in the UK, showing the
demand far exceeds the capacity to provide the treatment [6].
The 2014 changes to the guidelines should theoretically lower
the threshold for eligibility for bariatric surgery. When this is
combined with rising obesity levels [3], this suggests more
people should be eligible for bariatric surgery than previously
estimated. Despite this, the recent trends in data show that
between 2011/2012 and 2014/2015, the number of bariatric
surgeries performed in the UK fell from 8794 to 6384, a 27%
decrease [7]. Studies have shown bariatric surgery to have a
significant impact on obese patients, increasing both life ex-
pectancy and quality of life [8]. It has also been shown to be a
cost-effective treatment for patients, especially those with type
2 diabetes [9].
This study had a primary objective and two secondary ob-
jectives. The primary objective was to determine how many
people in England are eligible for bariatric surgery, under the
current NICE guidelines. Secondary objectives were to then
compare this with the previous guidelines and to compare
demographics from the eligible group with demographics of
those receiving surgery to examine whether there are health
inequalities in current service provision.
Materials and Methods
Participants and Data
This was a secondary data analysis of a cross-sectional survey
(Health Survey for England). Data was taken from the 2014
survey, downloaded from the UK data archive. The Health
Survey for England is designed to be nationally representative
by splitting the country into postcode groups before choosing
a random sample of households from each group (a stratified
probability sample) [10]. In each household, up to ten adults
and up to two children are eligible for inclusion in the final
dataset. In the 2014 survey, 9024 households were chosen at
random from the 564 postcodes. Initial interviews are per-
formed and then followed up by a visit from a trained nurse
where possible. Household response rate was 62% to give a
total sample size of 8077 adults aged 16 and above and 2003
children aged 0–15. Of these, 5491 adults and 1249 children
also had a nurse visit [11].
Participants under 16 were excluded from our study, as
were those without an accurate BMI result, or other missing
data. Current recommendations state that children and adoles-
cents should only be considered in extreme scenarios and even
then surgery should not be performed until they have reached
or nearly reached developmental maturity [5]. Not all obesity-
related comorbidities are specifically stated in the NICE
guidelines so these were determined from what is available
in the Health Survey for England and that is considered to be a
relevant comorbidity in the guidelines (type 2 diabetes, hyper-
tension) and from the advice of bariatric surgeons (osteoarthri-
tis, cardiovascular disease, stroke, hypercholesterolaemia).
BMI was available in the dataset and had been calculated
from measured height and weight, with measurements taken
at the interview stage. Type 2 diabetes status was estimated
from answers to questions regarding diabetes including age at
diagnosis, doctor confirmed diabetes, absence of pregnancy,
and gestational diabetes. Undiagnosed cases were identified
through an HbA1c blood test obtained at the nurse visit. A
participant was considered to have hypertension if they con-
firmed that a doctor had given them that diagnosis in the past,
or if examination of their prescribed medicines identified an
antihypertensive medication. Osteoarthritis status was self-
reported at the interview stage. Cardiovascular disease, stroke,
and hypercholesterolaemia status were self-reported at the in-
terview stage and/or identified by those taking relevant med-
ications (as determined by the Health Survey team).
During the interview stage, participants also self-reported
various sociodemographic variables, such as age, sex, ethnic-
ity, income, educational level, and employment status.
Data Analysis
SPSS 20 was used for computation and analysis of data.
Two sets of initial analyses were performed, one using the
new NICE guidelines from 2014 and one using the older 2006
guidelines. The main difference between the two was the rec-
ommendation in the 2014 guidelines relating to bariatric sur-
gery at a lower BMI than in the 2006 guidelines for patients
with recent-onset type 2 diabetes.
Participants were grouped according to BMI reflecting the
ranges of BMI that would be eligible for surgery. For the 2014
guidelines, this was generally non-eligible (< 30 kg/m2), eligible
with recent-onset type 2 diabetes (30–35 kg/m2), eligible with
obesity-related comorbidities (35–40 kg/m2), and eligible (>
40 kg/m2). For the 2006 guidelines, this was non-eligible (<
35 kg/m2), eligible with comorbidities (35–40 kg/m2), and eligi-
ble (> 40 kg/m2). In both groups, there were recommendations to
consider a lower threshold for the patients with an Asian
background. No specific figure was given in the guidelines
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but the briefing paper published before the guidelines was re-
leased suggested a figure of 2.5 kg/m2 lower for high-risk (BMI
≥ 30 kg/m2) patients with an Asian background [12], so the BMI
ranges used for each category were 2.5 kg/m2 lower for partici-
pants in this group.
Using Boolean operators, participants in the sample were
coded as eligible for surgery or non-eligible based on their
ethnicity and appropriate BMI category, and the identified
comorbidities. This determined the percentage of participants
(with a 95% confidence interval) that would be eligible for
bariatric surgery in England, calculated using Wilson’s scores
with continuity adjustments. Sociodemographic characteris-
tics were determined for the original sample and compared
with the eligible population, these were compared where pos-
sible with hospital episode statistics data. Frequencies were
compared and p values calculated using a chi-squared test.
Survey data was weighted to the general population using
weighting data suppliedwith the dataset to account for sampling
errors. Where results have been scaled to the general population
of England, an estimated figure of 46,550,257 adults (16 or
over) is used, based on mid 2014 population estimates and
calculated using the 2015 Office for National Statistics (ONS)
population data, using the available analysis tool [13].
Results
Number Eligible for Bariatric Surgery
There were a total of 6938 adults (over 16) in the sample once
those with invalid BMI data were excluded. After weighting,
the total sample size was 4996.1, with 388.9 participants eli-
gible for bariatric surgery. This is equivalent to 7.78% (95%
CL 7.07–8.58) of the sample. Scaling up for the population of
England, an estimated 3,623,505 people would have been
eligible for bariatric surgery in 2014.
Comparison with Old Guidelines
With the same sample but using the eligibility criteria from the
previous set of NICE guidelines, 291.7 participants were eligible,
equivalent to 5.84% of the population (95% CL 5.21–5.54).
Scaling results up to the population of 2014 gives an estimate
of 2,717,861 people. This means that the changes made in the
new guidelines increased the number that would be eligible for
surgery by an estimated 905,644 people or one third.
Comparison with HES Data for those Receiving
Surgery
The results from the sample showed that although a higher
proportion of females was eligible for surgery than males
(58.4% vs 41.7%), a disproportionately high number received
bariatric surgery (76.1% vs 23.9%), as seen in Table 1 and
Fig. 1. This was confirmed to be statistically significant (chi-
squared = 774.0, p = < 0.0001).
When split by age group, both those eligible and those
receiving surgery peaked at ages 45–54 (23.2% vs 34.2%).
There was a higher proportion eligible for surgery over the
age of 65 than those that received it (29.7% vs 4.00%) and a
lower proportion of those eligible under 35 compared with
those that received surgery (11.4% vs 18.6%). Overall, both
the eligible population and the surgical population had the
majority of cases in the 35–64 age groups, but the overall
proportion was lower in the eligible group (58.9% vs
77.5%). There was a significant difference in the distribution
of proportions of those eligible for surgery and those who
received it (chi-squared = 3115.9, p = < 0.0001) as seen in
Table 2 and Fig. 2.
There is a difference in surgery total for sex (6032) and age
group (6029). This is due to their being three under 16s who
received surgery who could not be removed from the analysis
for sex, as raw hospital episode statistics data were not
available.
Discussion
Main Findings
Results show that under the current NICE guidelines for obe-
sity, an estimated 3,623,505 or 7.78% (95% CL 7.07–8.58) of
the population could potentially be eligible for bariatric sur-
gery compared with 2,717,861 or 5.84% of the population
under the previous guidance (95% CL 5.21–5.54). These
numbers assume that those in the BMI 35–40 category have
attempted weight loss already through non-surgical means as
required by the NICE guidelines [5]. Although it was not
possible to ascertain who in that category had undertaken
non-surgical interventions, it is unlikely that many had.
However, evaluations of current medical and life style–
Table 1 Percentages of those estimated to be eligible and the
percentages of those receiving surgery by sex, the weighted figures for
who was eligible from the sample, and the numbers that received surgery
and the expected number if the proportions of those receiving surgery
were equal to the eligible group. Note that due to rounding, totals do not
always appear to be exactly 100%
Sex Eligible % Surgery % Eligible Surgery Expected
Male 41.7 23.9 161.8 1444 2509
Female 58.4 76.1 227.1 4588 3523
Total 100% 100% 388.9 6032 6032
Chi-squared 774.0
p value < 0.0001
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focused weight loss programmes show that weight loss that is
sustained by these programmes is often small, although sig-
nificant [14]. This means that it would be reasonable to as-
sume that most of those that are eligible would remain eligible
even after attempting non-surgical interventions. Certainly,
not everyone who is eligible for bariatric surgery should nec-
essarily be operated on. However, as the total number of bar-
iatric surgeries performed in the UK in 2014 was 6032 [7],
there is a large difference between potential treatment demand
and the availability of bariatric surgery. This penetration rate
of 0.002% is particularly low compared with other published
penetration rates, for example, 1.24% in the USA (where the
eligible population was defined as adults with BMI ≥ 40) [15]
and 0.54% in Canada in 2017 (where the eligible population
was defined as adults with BMI ≥ 35) [16].
Results also showed that although a higher proportion of
those eligible for surgery are female (~ 58% vs 42%), the
proportion of females who received surgery is significantly
higher (~ 76% vs 24%). There was also a significant differ-
ence in the age groups, with the eligible population being
skewed towards older age groups and those that receive sur-
gery being skewed towards younger age groups.
There does not appear to be a previous attempt to compare
the UK eligible population with hospital episode statistics da-
ta. The closest previous study, published in 2014 (but using
2006 data), produced a similar model for estimating who was
eligible using the previous NICE guidelines [6]. Their results
showed a similar pattern for demographics, although there
was a higher proportion eligible in the younger age groups
(18–24) and lower in the older age groups (65+) than in this
study. The overall estimate for eligible population from that
study was 5.1%, which compares closely with this study’s
results using the previous guidelines (5.8%), and may partly
be explained by considering the increases in obesity preva-
lence over the intervening eight years.
Limitations of this Study
The most important strengths and limitations come from the
use of the Health Survey for England. This data source is a
large, nationally representative sample with trustworthy data
including measured heights and weights, and nurse visits to
identify, for example—the medication that participants are
taking. However, the routine nature of the data collection,
rather than a bespoke design specific to our research question
means that some variables, we would have ideally had access
to, were unavailable. In addition, some conditions were only
self-reported, meaning the prevalence of some comorbidities
may be underestimated if they are undiagnosed.
Importantly, in terms of variables that were missing, there
were several relevant conditions that might indicate surgery
would be appropriate that were considered when planning this
study, including obstructive sleep apnoea and polycystic ova-
ry syndrome (additional to the comorbidities we did examine:
type 2 diabetes, hypertension, osteoarthritis, cardiovascular
disease, stroke, and hypercholesterolaemia). However, it was
not possible to obtain information on the presence of these
conditions from the Health Survey for England. The preva-
lence of some of the comorbidities chosen may have been
underestimated, for example hyperlipidaemia could only be
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Fig. 1 Showing the proportions of those eligible for surgery and those
receiving it in 2014 grouped by sex
Table 2 The percentages of those
estimated to be eligible and the
percentages of those receiving
surgery split by age group, the
weighted figures for who was
eligible from the sample, and the
numbers that received surgery
and the expected number if the
proportions of those receiving
surgery were equal to the eligible
group
Age Eligible % Surgery % Eligible Surgery Expected
16–24 4.5 3.3 17.7 200 274
25–34 6.9 15.3 26.8 920 415
35–44 12.9 25.4 50.1 1532 776
45–54 23.2 34.2 90.3 2064 1399
55–64 22.8 17.8 88.5 1074 1372
65–74 17.7 3.9 68.8 235 1067
75+ 12.0 0.1 46.8 4 725
Total 100% 100% 388.9 6029 6029
Chi-squared 3115.9
p vFweight losalue < 0.0001
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determined from those already taking lipid-lowering medica-
tions as there was not enough information to also include
those that were untreated but with a raised serum cholesterol.
Similarly, it was also difficult to distinguish between type 1
and type 2 diabetes. The Health Survey for England data used
a distinction of type 1 being Bdiagnosed before age 35, treated
with insulin^ and type 2 being Bdiagnosed after age 35, not
treated with insulin^. This could potentially underestimate the
number with type 2 diabetes; however, it was the best way to
distinguish between the two conditions with the data
available.
The NICE guidelines recommend an assessment for bar-
iatric surgery for those with a BMI of 30–34.9 kg/m2 with
recent-onset type two diabetes; however, there was not a
way to determine which of the cases of type 2 diabetes was
recent-onset so again, it is assumed that all those that had
type 2 diabetes were eligible. This may overestimate the
number eligible through this criterion, although the total
number of type 2 diabetes cases is believed to be higher
than estimated in this study. This study found the estimated
prevalence of diabetes of any type to be 6.1%, whereas
diabetes UK figures, based on the QOF data, reported the
prevalence of all types of diabetes in England to be around
6.2% in 2014 [17] and Public Health England estimated the
number to be around 8.6% [18], with 90% being type 2
diabetes (i.e. 7.7%).
Another possible source of error is a lack of detail in the
NICE guidelines. This is presumably to allow for clinical
judgement but it presented some difficulties when planning
this study. An example of this would be a definitive BMI
range for patients from an Asian background, with the
guidelines giving the recommendation to consider surgery
at a lower BMI range [2, 12]. Another issue was which
comorbidities to include, as a definitive list is not provided
in the guidelines. There was also a lack of detail at which
age surgery would usually be considered. The guidelines
do not give an exact lower age, only recommending that
surgery not be considered in Bchildren and young people^.
In the original study design, eighteen was chosen as a low-
er limit; however, when reviewing the hospital episode
statistics data for 2014/2015, it was decided that this
should be lowered to 16 to allow for an accurate compar-
ison, as the lowest age range in the data was 16–24 [7].
There is no stated upper age limit for surgery eligibility, as
decisions should be made on a case-by-case basis.
Implications of this Study
Possible reasons for low demand for bariatric surgery among
the eligible population include weight bias, which is high in
the UK [19]. Where obesity is attributed to personal irrespon-
sibility, demand, and referrals for bariatric surgery may well
be lower. Recent calls from the UK’s Royal College of
Physicians [20] to consider obesity a disease might counter
any reluctance to encourage bariatric surgery in those patients
who would benefit.
Other than the lack of bariatric surgery performed in com-
parison to demand, the main discussion points from this study
would be to determine why there is such a difference in the
sociodemographic proportions of who is eligible for surgery
and who receives it. The difference in age groups may be due
to older age groups being poor candidates for surgery or just
an attempt at earlier intervention to prevent chronic comorbid-
ities developing.
With regard to male and female populations, there may
be a difference in the proportion seeking medical attention
for weight-related issues, as well as concordance with
guidance and treatment plans. It is already known that
males are less likely to visit health care professionals due
to different attitudes towards health care [21]; however, it
is not known whether this relates to obesity-related condi-
tions. A previous study in California found that males who
presented for bariatric surgery were typically older and
with more severe comorbidities [22], showing a greater
need for earlier intervention in this group and greater po-
tential benefit from receiving surgery. An area for follow
up would be to speak to health care professionals, both in
primary care settings to see who seeks help for obesity-
related health problems and in secondary care to see who
is referred and how surgical candidates are identified. This
would help explain why there is such a difference and
address any potential barriers to treatment.
Further follow-up work could be undertaken to see if there
is a difference between eligibility and treatment in different
ethnic groups, different socioeconomic classes, or an urban
rural gradient. This would be dependent on the availability
of data relating to these groups and bariatric surgery.
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Conclusion
The potential demand for bariatric surgery in England outweighs
the availability of services. For a treatment deemed cost-effective
[9], increasing uptake of bariatric surgery could benefit the current
obesity crisis in England but would require significant investment
so that service provision is adequate for demand. There is also a
potential health inequality betweenwho requires surgery andwho
receives surgery, with females receiving a disproportionate num-
ber of the available surgeries. Further research is needed to iden-
tify if there are any barriers preventing access to treatment for
males or whether there is a problemwithmales seeking treatment
for obesity-related health problems and a more proactive ap-
proach is needed to identify males in need of treatment.
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